International Clinical Trials Day 2019
20 May 2019
Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.
We want to take today to say a special thank you to our wonderful Clinical Trials team, and extend our appreciation to the many thousands of dedicated people that undertake clinical trials to advance medicine and treatments for patients. Today is also an opportunity to recognise patients and their contribution to finding a cure by choosing to participate in our trials.
Our 20-person team based at the Poche Centre is currently coordinating 18 actively recruiting trials, while maintaining follow-up for a further 23. The trials coordinated by the team range from surgical and dermatological trials, through the spectrum of available medical and radiation oncology trials, including immunotherapy, targeted therapy, and radiation therapy. In 2018, 244 new patients were enrolled in clinical trials at MIA, while 665 were in the follow-up stages.
“We are very fortunate here at MIA to have an extremely hardworking and inspiring Clinical Trials team who are one hundred percent dedicated to our patients,” says Co-Medical Director Professor Richard Scolyer.
Co-Medical Director Professor Georgina Long adds, “Clinical trials lead to advances in treatment that create better outcomes for our patients – continually pushing the boundaries and conducting these trials is what is going to help us achieve our goal of zero deaths of melanoma.”
International Clinical Trials Day commemorates the day Scottish doctor James Lind began the first ever clinical trial in 1747, using different groups of sailors to identify the link between fruit and the prevention of scurvy. Lind changed modern medicine with his study, so every year International Clinical Trials Day is celebrated to appreciate and highlight the work of those in Clinical Trials.
Clinical Trials Manager Maria Gonzalez echoed the sentiments of the whole team, “We all come to work each day for the same reason: to help patients and find a cure.”
Melanoma patients are set to benefit from subsidised access to immunotherapy treatment for high risk early-stage and advanced-stage melanoma patients.
An informative article on how immunotherapy is revolutionising cancer treatment, written by Jill Margo and featured in the Australian Financial Review.
Melanoma patients and their families in the Riverina will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia.
Belmont High School at Lake Macquarie has been announced winner of the 2019 SunSafe Student Ambassador Program video competition.
It’s time again to say thank you to our amazing community fundraisers!
Videos of the sessions at the recent Patient Information Evening co-hosted by Melanoma Institute Australia (MIA) and Melanoma Patients Australia (MPA) are now available for viewing.
MIA is well-represented in the poster sessions at the Society for Melanoma Research 2019 Congress in the USA, with four poster presentations being given by members of our translational research lab.
Professor Georgina Long has today opened the Society for Melanoma Research 2019 Congress in Salt Lake City, Utah.
MIA’s Co-Medical Directors, Professor Georgina Long and Professor Richard Scolyer, have both been named Highly Cited Researchers, according to the Clarivate Analytics Highly Cited Researchers 2019 list.
Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA) have announced a new multi-year agreement to provide enhanced support services for melanoma patients nationally.
It is time again to say thank you to our incredible community fundraisers who are helping us get closer to our goal of zero deaths from melanoma.
MIA has presented promising data regarding progression-free survival rates for advanced melanoma patients at the ESMO 2019 Congress in Barcelona.
Another month has flown by and yet again we have a host of amazing community fundraisers who generously gave up their time to help us reach our goal of zero deaths from melanoma.
Comments in favour of giving patients with BRAF-positive melanoma access to first-line immunotherapy need to be submitted online prior to October 9, 2019.
Jay's Longest Melanoma March documentary is screening this Sunday 22 September at 1pm (AEST) on Channel 10, capturing behind the scenes of the 2000km walk, Adelaide to Sydney in 50 days. Uniting to end melanoma.
It’s been a month since we highlighted some of our incredibly generous community fundraisers. We thought we’d have a look back at August and put the spotlight on more of the wonderful people who give up their time to fundraise for MIA, so we can continue to edge closer to our goal of zero deaths from melanoma.
They are a formidable team - in work and in play
This week, Melanoma Institute Australia hosted the first of six